3B BlackBio Dx Limited Files SEBI Compliance Certificate for Q4FY26
3B BlackBio Dx Limited submitted its mandatory quarterly certificate under SEBI Depositories Regulations for Q4FY26 to BSE Limited on April 6, 2026. The filing, signed by Whole Time Director Nikhil Kuber Dubey, includes confirmation from RTA Adroit Corporate Services validating proper dematerialization processes and compliance with regulatory requirements for securities handling during the quarter ended March 31, 2026.

*this image is generated using AI for illustrative purposes only.
3B BlackBio Dx Limited has filed its quarterly compliance certificate with BSE Limited, fulfilling mandatory regulatory requirements under SEBI Depositories and Participants Regulations for the quarter ended March 31, 2026.
Regulatory Compliance Filing
The company submitted the certificate on April 6, 2026, in compliance with Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. The filing was signed by Nikhil Kuber Dubey, Whole Time Director (DIN: 00538049), and addressed to the Department of Corporate Relations at BSE Limited.
| Filing Details: | Information |
|---|---|
| Quarter Ended: | March 31, 2026 |
| Filing Date: | April 6, 2026 |
| Reference Number: | P-66/2026-27/3 |
| Signatory: | Nikhil Kuber Dubey, Whole Time Director |
| DIN: | 00538049 |
RTA Confirmation Certificate
Adroit Corporate Services Pvt. Ltd., serving as the company's Registrar and Share Transfer Agent, provided the confirmation certificate dated April 1, 2026. The RTA confirmed that securities received from depository participants for dematerialization during Q4FY26 were properly processed and confirmed to the depositories.
Key Compliance Confirmations
The RTA certificate validates several critical compliance aspects:
- Securities received for dematerialization were confirmed (accepted/rejected) to depositories
- Securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed
- Security certificates received for dematerialization have been mutilated and cancelled after due verification
- Depository names have been substituted in the register of members as registered owners within 15 days
Corporate Structure
The filing identifies the company as 3B BlackBio Dx Limited (Formerly, Kilpest India Limited), indicating a recent corporate restructuring or name change. The company maintains its registered operations from Bhopal, Madhya Pradesh.
This quarterly certification demonstrates the company's adherence to SEBI's regulatory framework governing depositories and participants, ensuring transparent and compliant securities handling processes throughout Q4FY26.
Historical Stock Returns for 3B BlackBio DX
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.23% | +8.79% | -2.16% | -11.90% | -27.32% | +262.27% |
What strategic business changes prompted 3B BlackBio Dx Limited's recent name change from Kilpest India Limited?
How might the company's transition into biotechnology diagnostics impact its financial performance in upcoming quarters?
Will 3B BlackBio Dx Limited require additional regulatory approvals from healthcare authorities given its apparent shift to biotech operations?


































